MYO18B and hepatocellular carcinoma: Although most studies on MYO18B in cancer support its role as a tumor suppressor, one report in hepatocellular carcinoma found that high MYO18B expression was associated with worse survival of this type of cancer, and knocking down MYO18B reduced proliferation and migration (Zhang et al., 2018).